Shenzhen New Industries Biomedical Engineering Co. Ltd Financials

Market Capitalization CN¥54.12 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	29.19
Forward PE	22.01
Price to Sales TTM	CN¥12.20
Price to Book MRQ	CN¥6.67
Enterprise to Revenue	11.89
Enterprise to EBITDA	24.61

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	41.72%
Operating Margin	42.57%
Return on Assets TTM	14.87%
Return on Equity TTM	24.32%

Income Statement

Revenue TTM	CN¥4,435,826,688
Revenue per Share TTM	CN¥5.65
Quarterly Revenue Growth	15.40%
Gross Profit TTM	CN¥2,867,179,699
EBITDA	CN¥2,127,060,221
Net Income to Common TTM	CN¥1,850,540,544
Diluted EPS TTM	CN¥2.36
Quarterly Earnings Growth YoY	10.00%

Balance Sheet

Total Cash MRQ	CN¥2,585,921,024
Total Cash per Share MRQ	CN¥3.29
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.06
Current Ratio MRQ	7.80
Book Value per Share MRQ	CN¥10.33

Cash Flow

Operating Cash Flow TTM	CN¥1,449,311,488
Levered Free Cash Flow TTM	CN¥967,299,904

300832 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	785,718,976
Float Shares	303,837,454
Avg 10 Volume	4,893,984
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	61.12%
% Held by Institutions	13.55%

Stock Price Summary

Beta	-0.43
Fifty Two Week Low	CN¥58.31
Fifty Two Week High	CN¥97.20
Fifty Two Week Change	-14.04%
Day 50 MA	CN¥68.90
Day 200 MA	CN¥69.76

Dividends and Splits

Forward Annual Dividend Rate	CN¥4.00
Forward Annual Dividend Yield	6.37%
Trailing Annual Dividend Rate	CN¥1.00
Trailing Annual Dividend Yield	1.59%
Payout Ratio	42.46%
Dividend Date
Ex Dividend Date	2024-05-15
Last Split Factor
Last Split Date	2021-05-21